Luxfer Holdings PLC (LXFR) Insider Trading

Last 12 months

Insiders sold $322k and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Director Patrick K Mullen sold $80k on Jun 11, 11% of their stake, outside a plan. The last open-market buy by an executive or director was in May 2025.

Net open-market

−$322k

0 buys · 5 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 5

executives and directors

Last open-market buy

May 2025

May 22, 2025

Get an email when LXFR's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jun 11	Richard J Hipple Director	SoldNo plan	4,010	$15.05	$60k	11%	Form 4
Jun 11	Lisa G Trimberger Director	SoldNo plan	4,010	$15.05	$60k	16%	Form 4
Jun 11	Sylvia Ann Stein Director	SoldNo plan	4,010	$15.05	$60k	21%	Form 4
Jun 11	Clive Snowdon Director	SoldNo plan	4,015	$15.05	$60k	13%	Form 4
Jun 11	Patrick K Mullen Director	SoldNo plan	5,323	$15.05	$80k	11%	Form 4
Jun 9, 2025	Stephen Webster Chief Financial Officer	SoldNo plan	4,244	$11.83	$50k	14%	Form 4
Jun 6, 2025	Sylvia Ann Stein Director	SoldNo plan	4,108	$10.02	$41k	29%	Form 4
Jun 5, 2025	Clive Snowdon Director	SoldNo plan	4,120	$10.02	$41k	16%	Form 4
Jun 5, 2025	Lisa G Trimberger Director	SoldNo plan	4,108	$10.02	$41k	21%	Form 4
Jun 5, 2025	Patrick K Mullen Director	SoldNo plan	5,463	$10.02	$55k	13%	Form 4
Jun 5, 2025	Richard J Hipple Director	SoldNo plan	4,108	$10.02	$41k	21%	Form 4
May 22, 2025	Graham Wardlow See Remarks	SoldNo plan	7,962	$11.33	$90k	24%	Form 4
May 22, 2025	Stephen Webster Chief Financial Officer	Bought	1,475	$11.53	$17k	7.0%	Form 4
May 20, 2025	Graham Wardlow See Remarks	SoldNo plan	4,874	$11.95	$58k	11%	Form 4
Nov 6, 2024	Mark James Lawday See Remarks	SoldNo plan	336	$15.04	$5k	9.9%	Form 4

Jun 11No plan
Richard J Hipple
Director · sold 4,010 at $15.05
$60k
11% of stake
Jun 11No plan
Lisa G Trimberger
Director · sold 4,010 at $15.05
$60k
16% of stake
Jun 11No plan
Sylvia Ann Stein
Director · sold 4,010 at $15.05
$60k
21% of stake
Jun 11No plan
Clive Snowdon
Director · sold 4,015 at $15.05
$60k
13% of stake
Jun 11No plan
Patrick K Mullen
Director · sold 5,323 at $15.05
$80k
11% of stake
Jun 9, 2025No plan
Stephen Webster
Chief Financial Officer · sold 4,244 at $11.83
$50k
14% of stake
Jun 6, 2025No plan
Sylvia Ann Stein
Director · sold 4,108 at $10.02
$41k
29% of stake
Jun 5, 2025No plan
Clive Snowdon
Director · sold 4,120 at $10.02
$41k
16% of stake
Jun 5, 2025No plan
Lisa G Trimberger
Director · sold 4,108 at $10.02
$41k
21% of stake
Jun 5, 2025No plan
Patrick K Mullen
Director · sold 5,463 at $10.02
$55k
13% of stake
Jun 5, 2025No plan
Richard J Hipple
Director · sold 4,108 at $10.02
$41k
21% of stake
May 22, 2025No plan
Graham Wardlow
See Remarks · sold 7,962 at $11.33
$90k
24% of stake
May 22, 2025
Stephen Webster
Chief Financial Officer · bought 1,475 at $11.53
$17k
7.0% of stake
May 20, 2025No plan
Graham Wardlow
See Remarks · sold 4,874 at $11.95
$58k
11% of stake
Nov 6, 2024No plan
Mark James Lawday
See Remarks · sold 336 at $15.04
$5k
9.9% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch LXFR, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Industrial Inorganic Chemicals

NLNL Industries Inc.

LXULsb Industries Inc.

KROKronos Worldwide Inc.

MTXMinerals Technologies Inc.

VHIValhi Inc.

TROXTronox Holdings plc

XERSXeris Biopharma Holdings, Inc.

DNLIDenali Therapeutics Inc.

Spot a number that looks wrong? Check it in LXFR's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing LXFR

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.